DIALYSIS · CCN 152599

USRC LAPORTE

LA PORTE, IN 46350

DialysisProfitUS Renal Care, Inc.
$2.3M
TOTAL REVENUE
-5.1%
OPERATING MARGIN
3 / 5
STAR RATING
15
QUALITY MEASURES
US Renal Care, Inc.
CHAIN
01 — FINANCIAL

Cost report financials (FY2025)

Net patient revenue
$2.3M
Total costs
$2.4M
Operating income (rev − costs)
−$116K
Operating margin
-5.1%
Total charges
$2.3M
Total treatments
6,684
Dialysis stations
12

Source: CMS dialysis cost reports. Operating margin = (net patient revenue − total costs) / net patient revenue.

02 — QUALITY MEASURES

15 quality measures

MeasureScoreDenominatorPeriod
Percent of Adult HD Patients with Kt/V >= 1.2
DFC_ADULT_HD_KTV
10036—
Standardized ED Visits Within 30 Days of Hospital Discharge
DFC_ED30
1.0549—
Fistula Rate
DFC_FISTULA_RATE
83.241—
Five Star Rating
DFC_FIVE_STAR
3——
First Year Standardized Kidney Transplant Waitlist Ratio
DFC_FYSWR
025—
Healthcare Worker COVID-19 Vaccination Adherence
DFC_HCP_VACC
0——
Patient Hospitalization Rate
DFC_HOSPITALIZATION_RATE
144.652—
Percentage of Adult Patients with Hypercalcemia
DFC_HYPERCALCEMIA
046—
Standard Infection Ratio (SIR)
DFC_INFECTION_RATIO
0——
Percentage of Adult Patients with Long Term Catheter in Use
DFC_LONG_CATHETER
241—
Patient Survival (Mortality Rate)
DFC_MORTALITY_RATE
22.8204—
Percentage of Prevalent Patients Waitlisted for Kidney Transplant
DFC_PPPW
4.538—
Patient Hospital Readmission Rate
DFC_READMISSION_RATE
24.446—
Standardized ED Visits Ratio
DFC_SEDR
0.9326—
Patient Transfusion Rate
DFC_TRANSFUSION_RATE
17.325—